(Q36028012)

English

Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Phase II study of high dose weekly intravenous human lymphoblastoid interferon in renal cell carcinoma. A study of the National Cancer Institute of Canada Clinical Trials Group (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

author name string

Eisenhauer EA

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Silver HK

2

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Venner PM

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Thirlwell MP

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Weinerman B

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Coppin CM

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

1 May 1987

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

55

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

541-542

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Phase I study of weekly high-dose human lymphoblastoid interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001718

2 October 2017

Interferon-alpha therapy of renal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001718

2 October 2017

Renal cell carcinoma: antitumor effects of leukocyte interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3606945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/3606945

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1987.110

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

release_wpavw3wrjbf37ci74cdmoqitwy

1 reference

https://api.fatcat.wiki/v0/release/wpavw3wrjbf37ci74cdmoqitwy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36028012&oldid=2198087266"